InnaMed is developing a connected portable blood testing device. Their platform technology enables patients to perform one-step proteomic assays at home. This frequent blood data allows providers to optimize biomarker guided therapies. InnaMed sees this as the future of personalized healthcare - using evidence-based interventions to reduce avoidable hospitalizations and improve short and long term patient outcomes.
Funding Rounds (5) - $781.14kUpdate
Current Team (2)Update
Palo Alto, California
3601 Market Street
Philadelphia, Pennsylvania 19104